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Abstract 
The crystal structure of the membrane protein prostaglandin H synthase (PGHS) provides trong evidence for the existence of monotopic membrane 
proteins: PGHS seems to interact with the membrane via a motif of amphipathic helices positioned parallel to the plane of the membrane. The 
orientation of this unique membrane binding motif is fixed in space by an epidermial growth factor(EGF)-like module on its amino-terminal end 
and by the catalytic domain at its carboxy-terminal end. The catalytic domain of PGHS has a high structural homology to other mammalian heme 
peroxidases. 
Key words: Membrane protein structure; Cyclooxygenase; Peroxidase; X-ray structure 
1. Introduction 
Arachidonic acid, a 20-carbon unsaturated essential 
fatty acid, is a natural component of membrane phos- 
pholipids and is released as a free fatty acid by stimuli- 
activated phospholipases AZ [ 11. The biftmctional enzyme 
prostaglandin H, synthase (PGHS) catalyzes the 8rst com- 
mitted step in the conversion of arachidonic acid, via a 
free radical mechanism, into prostaglandin Hz (PGH,), 
the precursor of all prostaglandins and thromboxanes 
[1,2]. The resulting am&donate derivatives are powerful 
modulators of many physiological processes including 
vasodilation, vasoconstriction, blood clotting, and in- 
flammation. Prostanoid biosynthesis and PGHS activity 
are implicated in pathophysiology of cancer, arthritis and 
cardiovascular disease [3-51 and PGHS is the primary 
target for nonsteroidal anti-inflammatory drugs [2]. 
PGHS was classified many years ago as a membrane 
protein on the basis of biochemical experiments: deter- 
gents are needed to extract PGHS from biological mem- 
branes and to maintain the enzyme in a solubilised state 
[2,6]. The nature of the substrate, arachidonic acid, made 
this hypothesis eem quite reasonable. Free arachidonate 
would most likely stay associated with the lipid bilayer 
and therefore the active site of PGHS should have some 
access to the hydrophobic milieu of the membrane. 
When amino acid sequences became available [7,8], at- 
tempts were made to identify the portions of the enzyme 
which interact with the membrane. The assignment of 
the most hydrophobic segment(s) as transmembrane was 
based on the use of standard methodologies [ 10,111; the 
different models proposed either one or two transmem- 
brane segments [2,7,9]. The three-dimensional structure 
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of the ovine PGHS isoenzyme-1 [12] showed clearly that 
the observed PGHS fold is not consistent with any model 
postulating transmembrane segments. The best model 
for the interaction of PGHS with the lipid bilayer in- 
volves the insertion of a motif of amphipathic helices into 
the membrane, creating a monotopic membrane protein 
as defined by Blobel [13]. 
2. The PGHS fold 
PGHS-1 exists, in the asymmetric unit of the crystal, 
as a symmetric dimer (Fig. la). The overall fold of PGHS 
can be describe as having a tripartite domain structure 
(Fig. lb). The amino-terminal portion begins with an 
epidermal growth factor(EGF)-like module (as defined 
by Campbell and Bork [14]), continues on with the mem- 
brane-binding domain, then ends with a large catalytic 
domain containing the two PGHS active sites: the cy- 
clooxygenase and the peroxidase active sites. The cy- 
clooxygenase active site, which catalyses the formation 
of prostaglandin GZ (PGG.J from arachidonic acid, re- 
sides at the apex of a long hydrophobic channel extend- 
ing from the membrane-binding domain to the center of 
the molecule [12]. This observation is quite consistent 
with the above-mentioned hypothesis that the enzyme 
should interact with the hydrophobic core of the bilayer. 
In contrast, the peroxidase active site, which catalyzes 
the reduction of PGG, to PGH,, is located on the other 
side of the molecule at the heme binding site (Fig. lb), 
away from the membrane-binding domain. The catalytic 
domain of PGHS-1 has a striking structural homology 
to the mammalian peroxidase, myeloperoxidase [ 12,151, 
a soluble protein. This observation strongly suggests that 
PGHS evolved from a soluble peroxidase ancestor, ac- 
quiring not only an internal, hydrophobic active site, but 
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Fig. 1. In (a), a schematic ribbon representation of the PGHS dimer with tubes representing a-helices. The two-fold symmetry axis is denoted by 
an arrow. In (b), the left-hand monomer of (a) is rotated 90” about the 2-fold axis and viewed from the dimer interface to show the domain structure 
of the enzyme. The general structural features, EGF-like module, cyclooxygenase active site channel (COX channel), membrane-binding (MB) domain 
and catalytic domain, are labeled. Note the positions of the helices labeled A, B, and C in the dimer. 
also the EGF-like module and the membrane-binding 
domain to allow direct interaction with the lipid bilayer. 
The functions of EGF-like modules are unknown, but 
they are thought to serve as structural building blocks 
that initiate or maintain protein-protein interactions 
and, perhaps, protein-membrane interactions [ 141. 
These modules, containing two small two-stranded /3- 
sheets held together by three intradomain disulfide 
bonds, are found in many extracellular proteins, blood 
clotting factors and cell-surface membrane proteins. The 
EGF-like module in PGHS is very similar to murine 
EGF [16] and to the second EGF-like module of Factor 
Xa [17]. The observed differences between the structures 
are due to the different lengths between the loops formed 
by the three disulfide bridges in the EGF-like modules. 
Least squares superposition of the 6 cysteine residues 
(using Ca, C/?, and Sy atoms) from any pair of EGF-like 
structures gives a RMS deviation on the order of 1.3-l .4 
A for the 18 atoms [12,17]. 
The EGF-like module is oriented with its carboxy- 
terminus just at the beginning of helix A in the mem- 
brane-binding domain and thus would be positioned 
close to the membrane surface. Three related observa- 
tions are of interest here. First, Kohda and Inagaki [18] 
have presented evidence that the carboxy-terminal por- 
tion of murine EGF can interact strongly with micelles 
of phopholipid analogs. Second, the homology between 
the amino-terminal domain of PGHS and EGF extends 
beyond the boundaries of sequence homology usually 
seen in EGF-like modules [14], persisting up to the 
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Fig. 2. In (a), a schematic of the PGHS monomer shown in Fig. la with residues in the membrane binding domain highlighted (light gray for polar, 
and dark gray for hydrophobic) to reveal the hydrophobic surface of the membrane binding motif. The conformation for the dimyristoyl phosphat- 
idylglycerol molecules @MPG) shown flanking the monomer was taken from Pascher et al. [40]. DMPG molecules are shown next to the membrane 
binding domain to denote roughly how PGHS might sit in the bilayer. In (b), a series of helical wheels for helices A, B, C and D are shown; the 
residues represented here are taken from the 6 published sequences for PGHS [7,3438]. The ‘pie’ in the center of the panel shows which residues 
from which PGHS sequence are at each position in helices A, B, C and D. 
Leu78-Arg79 dipeptide in PGHS, which falls in the mid- 
dle of helix A [12]. Lastly, another mammalian peroxi- 
dase, thyroid peroxidase, also exhibits high sequence ho- 
mology with myeloperoxidase in the catalytic domain 
[ 14,191. However, thyroid peroxidase is a membrane pro- 
tein, but unlike PGHS, thyroid peroxidase apparently 
has an EGF-like module at the carboxy-terminal portion 
of the sequence followed immmediately by a putative 
transmembrane anchor [ 191. These observations upport 
the hypothesis that EGF-like modules may be directly 
involved with protein-membrane interactions when they 
preceed a membrane-binding domain. 
The membrane binding domain, which follows the 
EGF-like module, is formed by a motif comprising three 
amphiphilic helices (A, B, C) which lie approximately in 
a plane (Fig. 1). The beginning of helix D is also am- 
phipathic but this fourth helix is more of a transitional 
structure in the motif as it connects the three first helices 
to the catalytic domain. The membrane-binding motif 
is held rigidly in position by the transitional helix D at 
its carboxy-terminus and by the EGF-like module at its 
amino-terminus. Moreover, the EGF-like module itself 
is anchored not only by the intradomain disulfide bond 
Cys37-Cys159, but also through extensive intersubunit 
interactions [12]. The surfaces of the helices A, B and C 
that face away from the catalytic domain are composed 
of hydrophobic residues (Fig. 2a). In the dimer (Fig. la), 
the two membrane-binding motifs therefore create an 
extensive hydrophobic surface along one side of the en- 
zyme [12]. 
3. Structural aspects of membrane interaction 
From the three-dimensional structure of PGHS, we 
have proposed a model for its insertion into the mem- 
brane [12] where the protein interacts with the membrane 
through the insertion of the membrane-binding motifs 
into the bilayer (Fig. 2a), in a manner suggested for 
surface-active peptides [20,21]. The protein, however, 
would not span the lipid bilayer and therefore PGHS is 
a monotopic membrane. The existence of monotopic 
membrane proteins have been postulated quite some 
time ago [13,22,23], but PGHS would be the first exam- 
ple where the three-dimensional structure has been deter- 
mined. From biochemical data examples of such mem- 
brane proteins are quite scarce: cytochrome b, [24] seems 
to form a monotopic interaction under some experimen- 
tal conditions and pyruvate oxidase [25] is linked to the 
membrane through an amphipathic peptide at the car- 
boxy-terminus. The extremely small number of clearly 
established monotopic membrane proteins led to the 
conclusion that they would be rare, perhaps for a variety 
of reasons [26]. These include the strong perturbation in 
the bilayer structure they would induce and the possible 
lack of insertion machinery for that type of protein struc- 
ture. The PGHS structure, on the other hand, suggests 
a more prosaic explanation: the observed ‘rarity’ of mon- 
otopic membrane proteins may be due to the difficulty 
in identifying them by their sequence. The identification 
of PGHS as a membrane protein from biochemical ex- 
periments and the lack of a sequence ‘signature’ for iden- 
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tifying putative monotopic membrane motifs essentially 
led to the wrong conclusions. The structure of PGHS 
offer thus the first opportunity to describe some of the 
structural characteristics of a monotopic membrane- 
binding motif. 
Over the past decade, several methods have been pub- 
lished for identifying putative transmembrane helices by 
virtue of the amino acid distribution [lO,ll]. With the 
determination of the bacterial photosynthetic reaction 
center structure [27,28], the sequence analysis of well- 
defined transmembrane helices could be made [28,29]. 
Using this limited structural information, others [30,31] 
have expanded the scope of the sequence analyses to 
identify and characterize of putative transmembrane he- 
lices in many membrane proteins of unknown tertiary 
structure. For example, Landolt-Marticorena et al. [31] 
have recently suggested that a consistent distribution of 
amino acids exists in transmembrane segments and their 
flanking regions for putative type I single span mem- 
brane proteins: (1) the hydrophobic region is dominated 
by aliphatic residues (Leu, Ile, Val), (2) the boundaries 
of the hydrophobic region are often demarcated by aro- 
matic residues (Phe, Tyr, Trp), and (3) the immediate 
flanking regions can be rich in Arg or Lys. The primary 
structure of a transmembrane helix would then vary in 
a predictable fashion as the helix reaches the membrane 
surface and enters into the hydrophobic milieu. As 
shown by earlier work [30], the cytoplasmic side of these 
putative transmembrane helices tend to have a greater 
concentration of cationic residues. The question now 
arises as to what might be the primary structure charac- 
teristics of a membrane-active helical motif, as we pro- 
pose, where the helices bind with their axes parallel to the 
membrane surface. Would they mimic transmembrane 
helices and show a distribution of amino acid residues 
across the helix similar to that found along transmem- 
brane helices or do they have a primary sequence struc- 
ture similar to ‘generic’ amphipathic helices on the sur- 
face of soluble proteins? 
White and colleagues [21,32,33] have provided an ap- 
propriate framework for analyzing membrane structure 
by studying the partitioning of small tripeptides into the 
lipid bilayer. They departed from a representation of the 
membrane as a single hydrocarbon slab and divided the 
membrane into three phases: a hydrophobic core region, 
an interfacial region and a solvent region. They also 
introduced the notion of a variable interfacial hydropho- 
bicity scale IFH(h) that describes the free energy for 
membrane interaction which depends on the level of sat- 
isfied hydrogen bonds. The variable h describes the state 
of hydrogen bond formation for a particular side chain 
(i.e. h = 0, for no H-bond formation; h = 1, when all 
possible H-bonds are formed). In other words, this scale 
allows one to take into account the effects of hydropho- 
bicity and the potential for H-bond formation for a par- 
ticular residue. In the hydrophobic core of the bilayer, 
residues like Trp, Tyr, Thr and Ser would have an unfa- 
vorable IFH(h) if all potential bonds could not be made 
(i.e. h near 0.0). When a residue moves toward the inter- 
face, where all possible H-bonds could be formed, the 
IFH(h = 1) then becomes very favorable for binding of 
a peptide at the membrane interface. They further stress 
that residues with a large surface will have a favorable 
interaction with the interface even if they are charged 
(for example Arg or Lys), provided that the charged 
group remains near the aqueous phase. To enter the 
hydrophobic core of the bilayer, a residue must therefore 
be part of a secondary structure element where nearly all 
possible main chain hydrogen bonds are satisfied. The 
experimentally derived IFH(h) scale therefore predicts 
the residues which could interact with the interfacial and 
hydrophobic regions of the bilayer, depending on the 
state of H-bond formation White and Wimley [33] also 
suggested that an a-helix provides an excellent secondary 
structural element for interaction with the bilayer inter- 
facial region. Given their observations, the amino acid 
composition across a membrane-embedded helix should 
mimic what others have found for transmembrane he- 
lices .
A comparison of the monotopic helices of three 
PGHS-1 sequences [7,34,35,] and three PGHS-2 se- 
quences [36-381, seen in Fig. 2b, clearly shows the strong 
tendency toward the conservation of the amphipathic 
nature of the membrane-binding motif. From this se- 
quence database, it is possible to create a ‘consensus’ 
helix for the membrane-binding motif represented by a 
helical wheel divided into four different sectors about 
helix axis: (a) an upper sector that would interact either 
with the solvent or with the protein and may therefore 
not have a unique sequence composition, (b) a lower or 
hydrophobic sector, thought to interact with the hydro- 
phobic core of the membrane, and, finally, (c) two inter- 
mediate sectors that describe the transition from the 
exterior to the interior of the membrane through the 
interfacial region defined by the lipid head groups. Fig. 
3 summarizes the distribution of the residues found in 
these four sectors as seen in helices A, B and C of the 
membrane-binding motif. 
On a qualitative level, this approach fits very well with 
the expected distribution for the residues involved in 
membrane-helix interaction, as predicted by the Jacobs 
and White model, particularly with regard to the localiz- 
ation of the aromatic residues Tyr and Trp in the interfa- 
cial regions. Furthermore, the distribution of amino acid 
residues across the censensus helix (Fig. 3) is very similar 
to what was found by Landolt-Marticorena et al. [3 l] for 
transmembrane helices (see above). The consensus helix 
may also allow one to approximate the localization of 
the helices relative to the membrane. The helices in the 
membrane-binding motif have an average diameter of 
14-16 A. The residues of the Sector 2 should be in the 
interface with the charged group facing the solvent or 
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Fig. 3. The series of helical wheels for helices A, B and C shown in Fig. 
2b have been reduced to a single ccnsensus helix and the helix was then 
divided into 4 spatial sectors. The amino acids that make up the major- 
ity of the residues in each sector are shown on the upper line and rarer 
substitutions are on the lower line. 
interacting with the charged headgroup of the lipids. 
Given the diameter of the helices, the lowest sector (Sec- 
tor 4 in Fig. 3) should interact with the hydrophobic core 
of the membrane, whereas the Sector 3 should be at the 
transition between the core and the inter-facial region. 
These observations, however preliminary, show again 
that the general principles that govern the interaction of 
membrane proteins with the lipid bilayer that were pro- 
posed by Singer and colleagues over thirty years ago 
[23,39], are still valid; but it also shows that the possibil- 
ities for satisfying these conditions are vaster than we 
have sometimes thought. 
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